Sera Prognostics to Present at 33rd Annual J.P. Morgan Healthcare Conference


SALT LAKE CITY, Dec. 23, 2014 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer, will present at the 33rd annual J.P. Morgan Healthcare Conference. Dr. Critchfield's presentation will take place at 4:30 p.m. PT on Wednesday, January 14, 2015 at the Westin St. Francis Hotel in San Francisco, CA.

About Sera Prognostics, Inc.

Sera Prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth and other pregnancy complications. Sera's tests are designed to help better inform the care of a mother and her unborn child during pregnancy, and potentially lead to improved health. The company has assembled a strong management team and Board of Directors with significant clinical development and women's healthcare diagnostic experience. Sera's Proteomic Assessment of Preterm Birth study is fully enrolled, as one of the world's largest and broadest clinical trials to validate the performance of the Company's PreTRM™ Test for predicting the risk of preterm birth. Sera Prognostics is located in Salt Lake City, Utah. For more information, please visit the company's website at www.seraprognostics.com.



            

Contact Data